UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 294

Sortiert nach

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

Cancers, 2019-08, Vol.11 (8), p.1191

2019

Volltextzugriff (PDF)

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (19), p.8788-8793

2010

Volltextzugriff (PDF)

Mitochondrial Metabolism and Cancer

Annals of the New York Academy of Sciences, 2009-10, Vol.1177 (1), p.66-73

2009

Volltextzugriff (PDF)

Cyclin-dependent kinase inhibitors for the treatment of lung cancer

Expert opinion on pharmacotherapy, 2020-05, Vol.21 (8), p.941-952

2020

Volltextzugriff (PDF)

Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio

Free radical biology & medicine, 2009-05, Vol.46 (10), p.1386-1391

2009

Volltextzugriff (PDF)

PTEN Regulates p300-Dependent Hypoxia-Inducible Factor 1 Transcriptional Activity through Forkhead Transcription Factor 3a (FOXO3a)

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (7), p.2622-2627

2008

Volltextzugriff (PDF)

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?

Cancers, 2020-12, Vol.13 (1), p.13

2020

Volltextzugriff (PDF)

Neighborhood-level deprivation and survival in lung cancer

BMC cancer, 2024-08, Vol.24 (1), p.1-11, Article 959

2024

Volltextzugriff (PDF)

Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

Translational lung cancer research, 2018-09, Vol.7 (S3), p.S243-S247

2018

Volltextzugriff (PDF)

Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)

Journal of thoracic disease, 2021-02, Vol.13 (2), p.986-994

2021

Volltextzugriff (PDF)

The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer

Cancers, 2022-10, Vol.14 (21), p.5305

2022

Volltextzugriff (PDF)

chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation

Proceedings of the National Academy of Sciences - PNAS, 2008-01, Vol.105 (1), p.174-179

2008

Volltextzugriff (PDF)

Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.8811-8815

2004

Volltextzugriff (PDF)

Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS

The FASEB journal, 2009-03, Vol.23 (3), p.783-794

2009

Volltextzugriff (PDF)

Large Deletions of the PRKAR1A Gene in Carney Complex

Clinical cancer research, 2008-01, Vol.14 (2), p.388-395

2008

Volltextzugriff (PDF)

Reactive oxygen species-dependent signaling regulates cancer

Cellular and molecular life sciences : CMLS, 2009-12, Vol.66 (23), p.3663-3673

2009

Volltextzugriff (PDF)

Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines

Molecular cancer therapeutics, 2006-07, Vol.5 (7), p.1783-1789

2006

Volltextzugriff (PDF)

Synthetic lethality: a step forward for personalized medicine in cancer

Drug discovery today, 2020-02, Vol.25 (2), p.305-320

2020

Volltextzugriff (PDF)

Corrigendum to ‘Synthetic lethality: a step forward for personalized medicine in cancer’ [Drug Discov. Today 25 (2020) 305–320]

Drug discovery today, 2021-08, Vol.26 (8), p.2077-2077

2021

Volltextzugriff (PDF)

The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment

The cancer journal (Sudbury, Mass.), 2023-03, Vol.29 (2), p.61

2023

Volltextzugriff (PDF)

Random generation of RNA secondary structures according to native distributions

Algorithms for molecular biology, 2011-10, Vol.6 (1), p.24-24, Article 24

2011

Volltextzugriff (PDF)

PP01.41 Clinical Trial Enrollment Success of Underrepresented Patients with Lung Cancer at a Single Institution

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e23-e23

2024

Volltextzugriff (PDF)

PP01.96 Characterization of DNA damage repair mutations in lung cancer in an underserved urban patient population

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e42-e43

2024

Volltextzugriff (PDF)

PP01.52 The Effect of Altered RNA Expression on Tumor Immune Infiltration in NSCLC: A Retrospective NGS Study

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e26-e26

2024

Volltextzugriff (PDF)

PP01.100 KRAS/TP53 Co-Mutation is Associated with Increased Tumor Immunogenicity in Non-Small Cell Lung Cancer Patients

Journal of thoracic oncology, 2024-07, Vol.19 (7), p.e44-e44

2024

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(248)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(289)
Japanisch
(33)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

Mitochondrial Metabolism and Cancer

Cyclin-dependent kinase inhibitors for the treatment of lung cancer

Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio

PTEN Regulates p300-Dependent Hypoxia-Inducible Factor 1 Transcriptional Activity through Forkhead Transcription Factor 3a (FOXO3a)

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?

Neighborhood-level deprivation and survival in lung cancer

Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)

The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer

chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation

Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors

Hyperoxia-induced premature senescence requires p53 and pRb, but not mitochondrial matrix ROS

Large Deletions of the PRKAR1A Gene in Carney Complex

Reactive oxygen species-dependent signaling regulates cancer

Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines

Synthetic lethality: a step forward for personalized medicine in cancer

Corrigendum to ‘Synthetic lethality: a step forward for personalized medicine in cancer’ [Drug Discov. Today 25 (2020) 305–320]

The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment

Random generation of RNA secondary structures according to native distributions

PP01.41 Clinical Trial Enrollment Success of Underrepresented Patients with Lung Cancer at a Single Institution

PP01.96 Characterization of DNA damage repair mutations in lung cancer in an underserved urban patient population

PP01.52 The Effect of Altered RNA Expression on Tumor Immune Infiltration in NSCLC: A Retrospective NGS Study

PP01.100 KRAS/TP53 Co-Mutation is Associated with Increased Tumor Immunogenicity in Non-Small Cell Lung Cancer Patients

Suchergebnisse filtern